Hydrophobicity drives the systemic distribution of lipid-conjugated siRNAs via lipid transport pathways

Nucleic Acids Res. 2019 Feb 20;47(3):1070-1081. doi: 10.1093/nar/gky1232.

Abstract

Efficient delivery of therapeutic RNA beyond the liver is the fundamental obstacle preventing its clinical utility. Lipid conjugation increases plasma half-life and enhances tissue accumulation and cellular uptake of small interfering RNAs (siRNAs). However, the mechanism relating lipid hydrophobicity, structure, and siRNA pharmacokinetics is unclear. Here, using a diverse panel of biologically occurring lipids, we show that lipid conjugation directly modulates siRNA hydrophobicity. When administered in vivo, highly hydrophobic lipid-siRNAs preferentially and spontaneously associate with circulating low-density lipoprotein (LDL), while less lipophilic lipid-siRNAs bind to high-density lipoprotein (HDL). Lipid-siRNAs are targeted to lipoprotein receptor-enriched tissues, eliciting significant mRNA silencing in liver (65%), adrenal gland (37%), ovary (35%), and kidney (78%). Interestingly, siRNA internalization may not be completely driven by lipoprotein endocytosis, but the extent of siRNA phosphorothioate modifications may also be a factor. Although biomimetic lipoprotein nanoparticles have been explored for the enhancement of siRNA delivery, our findings suggest that hydrophobic modifications can be leveraged to incorporate therapeutic siRNA into endogenous lipid transport pathways without the requirement for synthetic formulation.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Blood Proteins / metabolism
  • Female
  • HeLa Cells
  • Hepatocytes / metabolism
  • Humans
  • Hydrophobic and Hydrophilic Interactions
  • Kidney / metabolism
  • Lipids / chemistry*
  • Lipoproteins, LDL / metabolism
  • Mice
  • RNA Interference
  • RNA, Small Interfering / chemical synthesis
  • RNA, Small Interfering / chemistry
  • RNA, Small Interfering / pharmacokinetics*
  • Receptors, LDL / metabolism
  • Tissue Distribution

Substances

  • Blood Proteins
  • Lipids
  • Lipoproteins, LDL
  • RNA, Small Interfering
  • Receptors, LDL